
To help answer some of the questions you may have about IMFINZI + IMJUDO with chemotherapy or Stage 4 non-small cell lung cancer (NSCLC), check out the frequently asked questions below.
Remember, your doctor is the best resource for answering specific questions about your treatment.
Stage 4 non-small cell lung cancer is adenocarcinoma, squamous cell carcinoma, or large cell carcinoma that has spread to both lungs, to fluid in the areas around the lungs or the heart, or away from the lungs to another part of the body.
IMFINZI + IMJUDO with chemotherapy is an immunotherapy-based treatment to treat Stage 4 non-small cell lung cancer.
IMFINZI and IMJUDO are immunotherapies. An immunotherapy is a type of cancer treatment that works with your immune system to find and attack cancer cells. IMFINZI + IMJUDO may also affect healthy cells.
Chemotherapy attacks fast-growing cells, including cancer cells and sometimes healthy cells. Immunotherapies, like IMFINZI and IMJUDO, work with your immune system to find and attack cancer cells.
IMFINZI + IMJUDO with chemotherapy may cause the immune system to attack healthy cells.
IMFINZI + IMJUDO are intravenous (IV) infusions given at your doctor’s office or an infusion center. You’ll receive IMFINZI + IMJUDO in combination with chemotherapy.
The number of treatments will be determined by your doctor.
While on IMFINZI + IMJUDO with chemotherapy, you may experience side effects. This is because IMFINZI + IMJUDO can cause your immune system to attack normal organs and tissues and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with IMFINZI, if you have severe side effects.
Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the side effects of IMFINZI + IMJUDO with chemotherapy. Please see complete Important Safety Information below and Full Prescribing Information, including Medication Guide, for IMFINZI and IMJUDO.
IMFINZI and IMJUDO are medicines that may treat certain cancers by working with your immune system. IMFINZI and IMJUDO can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.
IMFINZI and IMJUDO are prescription medicines used to treat adults with a type of lung cancer called NSCLC. IMFINZI may be used in combination with IMJUDO and chemotherapy that contains platinum when your NSCLC has spread to other parts of your body (metastatic) and your tumor does not have an abnormal “EGFR” or “ALK” gene.
It is not known if IMFINZI and IMJUDO are safe and effective in children.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with IMFINZI and IMJUDO. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with IMFINZI and IMJUDO if you have severe side effects
Before you receive IMFINZI and IMJUDO, tell your healthcare provider about all of your medical conditions, including if you:
Females who are able to become pregnant:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of IMFINZI when used in combination with IMJUDO and platinum-containing chemotherapy in adults with metastatic non-small cell lung cancer (mNSCLC) include nausea, feeling tired or weak, muscle or bone pain, decreased appetite, rash, and diarrhea.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of IMFINZI and IMJUDO. Ask your healthcare provider or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects related to AstraZeneca products. If you prefer to report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Call your doctor for medical advice about side effects. You may report side effects related to AstraZeneca products. If you prefer to report these to the FDA, either visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
IMFINZI and IMJUDO are prescription medicines used to treat adults with a type of lung cancer called NSCLC. IMFINZI may be used in combination with IMJUDO and chemotherapy that contains platinum when your NSCLC has spread to other parts of your body (metastatic) and your tumor does not have an abnormal “EGFR” or “ALK” gene.
It is not known if IMFINZI and IMJUDO are safe and effective in children.
Please see Full Prescribing Information including Medication Guide for IMFINZI and IMJUDO.
IMFINZI and IMJUDO are medicines that may treat certain cancers by working with your immune system. IMFINZI and IMJUDO can...
IMFINZI and IMJUDO are medicines that may treat...
IMFINZI and IMJUDO are prescription medicines used to treat adults with a type of lung cancer called NSCLC. IMFINZI may be used in combination with IMJUDO and chemotherapy that ...
IMFINZI and IMJUDO are medicines that may treat certain cancers by...
IMFINZI and IMJUDO are medicines that may treat certain cancers by working with your immune system. IMFINZI and IMJUDO can...